IL-18

Inflammasome-derived cytokine

Expression
elevated
Evidence level
strong

Role in pathogenesis

Independently drives skin inflammation in mouse models (divergent from IL-1 pathway). Elevated in CAPS patients. No approved IL-18-targeted therapy for CAPS.

Sources (2)

B5Brydges SD et al. (2013) Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies · J Clin InvestPubMed
B2Molina-López C et al. (2024) Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1β production · Nat CommunPubMed